e-learning
resources
Virtual 2020
Pre-Congress Content
Occupational exposure as a cause of respiratory disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Peculiarities of pulmonary alveolar proteinosis (PAP) due to exogenous factors
G. Orlova (St. Petersburg, Russian Federation), A. Speranskaya (St. Petersburg, Russian Federation), I. Dvorakovskaya (St. Petersburg, Russian Federation)
Source:
Virtual Congress 2020 – Occupational exposure as a cause of respiratory disease
Session:
Occupational exposure as a cause of respiratory disease
Session type:
E-poster session
Number:
662
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Orlova (St. Petersburg, Russian Federation), A. Speranskaya (St. Petersburg, Russian Federation), I. Dvorakovskaya (St. Petersburg, Russian Federation). Peculiarities of pulmonary alveolar proteinosis (PAP) due to exogenous factors. 662
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
A 12-year-old male child with fever, productive cough and sudden onset paralysis
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Treatment of pulmonary alveolar proteinosis (PAP) with administration of GM-CSF
Source: Eur Respir J 2002; 20: Suppl. 38, 447s
Year: 2002
Our cases with pulmonary alveolar proteinosis
Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs)
Year: 2018
Pulmonary alveolar proteinosis
Source: Respipedia Article
Year: 2017
Possible ocular involvement in pulmonary alveolar proteinosis
Source: Eur Respir J 2006; 28: 456
Year: 2006
Pulmonary alveolar proteinosis
Source: Eur Respir Mon; 2009: 46: 208–224
Year: 2009
Pulmonary alveolar proteinosis
Source: Eur Respir Rev 2011; 20: 98-107
Year: 2011
Surfactant proteins in pulmonary alveolar proteinosis in adults
Source: Eur Respir J 2004; 24: 426-435
Year: 2004
Mini-whole lung lavage to treat pulmonary alveolar proteinosis (PAP)
Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key
Year: 2020
Abnormal intraalveolar accumulation of surfactant proteins in adults with pulmonary alveolar proteinosis
Source: Eur Respir J 2002; 20: Suppl. 38, 90s
Year: 2002
Pulmonary alveolar proteinosis: from classification to therapy
Source: Breathe, 16 (2) 200018; 10.1183/20734735.0018-2020
Year: 2020
PAS-negative pulmonary alveolar proteinosis
Source: Annual Congress 2008 - Rare clinical cases
Year: 2008
Lung cysts in pulmonary alveolar proteinosis.
Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs)
Year: 2018
The role of apoptosis in idiopathic pulmonary alveolar proteinosis
Source: Annual Congress 2006 - Usefulness of broncoalveolar lavage (BAL) in interstitial lung diseases
Year: 2006
Pulmonary alveolar proteinosis (PAP) - clinical features and response to treatment by bronchofiberoscopic lobar lavage
Source: Eur Respir J 2005; 26: Suppl. 49, 541s
Year: 2005
Treatment of severe pulmonary alveolar proteinosis using inhaled GM-CSF
Source: Annual Congress 2010 - Rare diffuse lung diseases
Year: 2010
Determinants of protein concentration in whole lung lavage of patients with pulmonary alveolar proteinosis
Source: Annual Congress 2009 - From genetics to clinics in diffuse parenchymal lung diseases
Year: 2009
Pulmonary alveolar proteinosis and idiopathic pulmonary hemosiderosis
Source: International Congress 2019 – CCC Airway diseases
Year: 2019
Pulmonary alveolar proteinosis and GMSCF antibodies: a case series
Source: Eur Respir J 2004; 24: Suppl. 48, 670s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept